Artificial Intelligence-Enabled Stool Analysis For Lactulose Titration Assistance In Hepatic Encephalopathy Via A Smartphone Application

Beatriz Sordi Chara,Kamalpreet S. Hara,Daniel Penrice,Kathryn A. Schmidt,Blake A. Kassmeyer,Jacob Anstey,David Tiede,Patrick S. Kamath,Vijay H. Shah,Jasmohan S Bajaj,Asaf Kraus,Douglas A. Simonetto
DOI: https://doi.org/10.14309/ajg.0000000000002656
2024-01-21
The American Journal of Gastroenterology
Abstract:Background: Management of hepatic encephalopathy relies on self-titration of lactulose. In this feasibility trial, we assess an artificial intelligence-enabled tool, to guide lactulose use via a smartphone app. Methods: Subjects with hepatic encephalopathy on lactulose captured bowel movement pictures during lead-in and intervention phases. During the intervention phase daily feedback on lactulose titration was delivered through the app. Goals were determined according to number of bowel movement and Bristol Stool Scale reports. Results: Subjects completed the study with over 80% satisfaction. In the lead-in phase, less compliant subjects achieved Bristol Stool Scale goal on 62/111 (56%) of days compared to 107/136 (79%) in the intervention phase (p=0.041), while the most compliant subjects showed no difference. Severe/recurrent hepatic encephalopathy group achieved Bristol Stool Scale goal on 80/104 (77%) days in the lead-in and 90/110 (82%) days in the intervention phase(p=NS), compared to 89/143 (62%) days and 86/127 (68%) days in the stable group. Conclusion: Dieta® app is a promising tool for objective Bowel Movement/ Bristol Stool Scale tracking for HE and may potentially be used to assist with lactulose titration.
gastroenterology & hepatology
What problem does this paper attempt to address?